chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I had the second shot on April 30th 2021, and then 9 hours later I had mild headache. The day after on May 1st 2021, I started feeling body/muscle aches on around 11:00am. After 6 hours around 5pm the intensity increased. Took 1gr of Tylenol in total each of 500mg which relieved symptoms a little bit. Around 2am on May 2nd 2021, I woke up with severe body ache and feeling of 'electricity' throughout my body with skin sensitivity. Note that the symptoms from the first Pfizer vaccine did not completely disappeared even 3 weeks after administration. The symptoms and reactions were submitted in separate form from this one.
Information has been received from a health professional concerning an 18 year old female with a history of epilepsy, who on 03MAY-2007 was vaccinated with her first dose of Gardasil vaccine. The patient had an abnormal Pap test before and after her first vaccination. On 09-JUL-2007, the patient was vaccinated with her second dose of Gardasil vaccine. After her second vaccination, the patient tested positive for high risk HPV. Concomitant therapy included Tegretol. The patient's condition persisted. The patient denies sexual activity. The patient sought medical attention with the Physician's Assistant (PA). Additional information has been requested.
Vertigo. Dizziness upon laying down and standing up again. Severe enough to cause room to spin.
Red area; Red hot fever; Pain at the injection site; Left arm swollen (4 inches long and 5 inches wide); This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Red area), PYREXIA (Red hot fever), VACCINATION SITE PAIN (Pain at the injection site) and VACCINATION SITE SWELLING (Left arm swollen (4 inches long and 5 inches wide)) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 046B21ATCP4 and 008B212ATCP4) for COVID-19 vaccination.     No medical history provided.  The patient's past medical history included Pacemaker insertion (cardiac) (Had a pacemaker put in 3 years ago). Concomitant products included OSEDRATE for an unknown indication.   On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ERYTHEMA (Red area), PYREXIA (Red hot fever), VACCINATION SITE PAIN (Pain at the injection site) and VACCINATION SITE SWELLING (Left arm swollen (4 inches long and 5 inches wide)). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, ERYTHEMA (Red area), PYREXIA (Red hot fever), VACCINATION SITE PAIN (Pain at the injection site) and VACCINATION SITE SWELLING (Left arm swollen (4 inches long and 5 inches wide)) outcome was unknown.
I was vaccinates at around 3pm on 02/02/2021.   Everything was fine throughout the day and night.  On 02/03/2021 at around 1:30pm I started to feel different.  At around 4pm I am sick. I have a fever, I feel sweaty, my muscles hurt and I have body aches.  I left work at around 4pm
This is a spontaneous report from a contactable nurse reporting on behalf of a physician received via a sales representative. A 57-years-old other ethnic group female patient received PREVNAR 13 (lot L99271, Exp. date 30Mar2017), intramuscular on arm on 23Sep2015 at 0.5 ml, single dose. Medical history included ongoing diabetes mellitus, hypothyroidism, hypertension, glaucoma, blood cholesterol increased. On the same date the patient received also a dose of FLUZONE QUADRIVALENT (lot U1443AC) and ENGERIX-B (lot 9937B) both intramuscular on left arm. On 24Sep2015 the patient experienced cellulitis, fever and chills. The patient outcome was reported as recovering for cellulitis and recovered on unknown date for fever and chills. Therapeutic measures were taken as a result of the events. The patient went to the emergency room with cellulitis and fever after receiving the vaccines but was not admitted and was put on an antibiotic.
pt recieved influenza and pneumonia vaccine on 11/12/07. Pneumonia was administered in right deltoid muscle. Wife called on 11/13/07 & stated pts right arm was sore, red & inflammed and was also complaining of headache. She stated symptoms began last night and that patient did not sleep during the night. Wife was advised to give acetaminaphen or ibuprofen for discomfort. Also to treat injection site with warm compresses and give diphenhyramine to help relieve symptoms. Follow up at 5:00pm 11/13 patient was doing better, headache was gone and redness on arm was clearing.
On 08/22/2005 DTap was given on right deltoid area. On 08/23/2005 pt came H/O pain and swelling of right deltoid area 4 x 4 erythema, hot to touch, mild tenderness.
I63.511 ACUTE STROKE DUE TO OCCLUSION OF RIGHT MIDDLE CEREBRAL ARTERY 3/18/2023 LETHARGY I63.511 ACUTE STROKE DUE TO OCCLUSION OF RIGHT MIDDLE CEREBRAL ARTERY 3/18/2023 ACUTE STROKE DUE TO OCCLUSION OF RIGHT MIDDLE CEREBRAL ARTERY
A little more than 24 hours after my booster, my heart began to race and have an irregular rhythm, worse from any exertion, much worse from climbing stairs or walking just a few feet up a slight incline. My heart felt as if it would beat out of my chest. I also had difficulty catching my breath, had pain in my chest and throat, was dizzy and had a headache. The side effects subsided overnight.  Today, 04/15, is one week after the initial onset of side effects, and I am again having discomfort while breathing and a headache, along with some other odd sensations in my upper body.  I have no personal or family history of heart disease or atherosclerosis, and have a normal lipid profile.  I have not sought medical care for these symptoms.
Patient had a tick bite earlier in the summer. Symptoms began on 10/24/2017. The first symptom was tingling of the right face. Patient went to the ED with right face drooping and was diagnosed with Bell's Palsy. Patient had difficulty closing his eye, no hearing sensitivities, some taste issues on Monday 10/23/2017. He was seen by his PCP on 10/26/2017 as an ED follow up and with enlarged lymph nodes. Patient was treated with Doxycycline Hyclate and Prednisone in the ED.
5/4/21 presenting to the emergency department for evaluation of cardiac arrest. Prior to arrival, the patient received his second COVID shot. While there, he went into v-fib arrest.  Acute inferior posterior myocardial infarction with out-of-hospital cardiac arrest
Initial report received from a healthcare professional on 02/Sep/2005; A 43-year-old female patient received DECAVAC, lot number U1370CA, intramuscularly in the left deltoid on 29/Aug/2005. Two days later, she developed a local reaction of redness, as well as regional lymphadenopathy. She also felt a "pulling sensation" around the abdomen and back. The patient was examined in an emergency department on 01/Sep/2005 and was diagnosed with post-vaccination viremia. She was treated with Motrin and Duracef. The patient was reevaluated by a physician on 02/Sep/2005. CBC and chemistry results from the emergency department were reported as normal. At the time of this report, the patient had not recovered from the events.
sore arm for 24 hours after the second dose; experienced for 24 hours chills after the Moderna's second dose; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (sore arm for 24 hours after the second dose) and CHILLS (experienced for 24 hours chills after the Moderna's second dose) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012A21A and 011M20A) for COVID-19 vaccination.     Previously administered products included for Product used for unknown indication: INFLUENZA VACCINE (Flu shot). Past adverse reactions to the above products included No adverse event with INFLUENZA VACCINE. Concurrent medical conditions included Hypercholesteraemia (No recent change in status of chronic condition) since 08-Jan-2005. Concomitant products included ATORVASTATIN from 08-Jan-2005 to an unknown date for an unknown indication.   On 29-Jan-2021 at 9:30 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Feb-2021 at 10:30 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 24-Feb-2021, the patient experienced VACCINATION SITE PAIN (sore arm for 24 hours after the second dose) and CHILLS (experienced for 24 hours chills after the Moderna's second dose). On 25-Feb-2021, VACCINATION SITE PAIN (sore arm for 24 hours after the second dose) and CHILLS (experienced for 24 hours chills after the Moderna's second dose) had resolved.            No treatment details were reported. Patient did not have any acute illness at the time  of vaccination and up to one month before. Patient was not sure if the flu shot was behaving like a booster, or if it was not fully effective because it might  reacted with the Moderna vaccine, or if the second set of chills from the flu shot means nothing important. patient  received the high dose flu shot Fluzone HD QUAD 2021-22 PFS shot and experienced chills for 4 hours (9pm 21sep21-1am 22sep21), the onset was 12 hours after shot.  also has a little sore arm, vaccine was administered in the wrong part of the arm and it bled a little. He have never in the past had chills after the flu shot (left arm).   Most recent FOLLOW-UP information incorporated above includes: On 27-Sep-2021: Follow up was received and added additional reporter, patient race, ethnicity, height and weight. Patient lab test and current condition was added. Updated  suspect dose time, and added cosuspect as Fluzone and concomitant dose, frequency and start date was updated. Event outcome and intensity was updated for chills after flushot. On 27-Sep-2021: Non-Significant Follow up-Document attachment consists of no new information
flu-like symptoms; pain and achiness all over; incredible fatigue/extreme fatigue for at least 2-3 days every week/felt so tired all the time; fever of 101.5 degrees Fahrenheit; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (flu-like symptoms), MYALGIA (pain and achiness all over), FATIGUE (incredible fatigue/extreme fatigue for at least 2-3 days every week/felt so tired all the time) and PYREXIA (fever of 101.5 degrees Fahrenheit) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 27A21A and 012M20A) for COVID-19 vaccination.     Concurrent medical conditions included Seasonal allergy. Concomitant products included ROSUVASTATIN CALCIUM (CRESTOR), MULTIVITAMINS [VITAMINS NOS] and VITAMIN D [VITAMIN D NOS] for an unknown indication.   On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 09-Mar-2021, the patient experienced INFLUENZA LIKE ILLNESS (flu-like symptoms), MYALGIA (pain and achiness all over), FATIGUE (incredible fatigue/extreme fatigue for at least 2-3 days every week/felt so tired all the time) and PYREXIA (fever of 101.5 degrees Fahrenheit). The patient was treated with PARACETAMOL (TYLENOL) for Fever, at an unspecified dose and frequency. At the time of the report, INFLUENZA LIKE ILLNESS (flu-like symptoms), MYALGIA (pain and achiness all over), FATIGUE (incredible fatigue/extreme fatigue for at least 2-3 days every week/felt so tired all the time) and PYREXIA (fever of 101.5 degrees Fahrenheit) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 09-Mar-2021, Body temperature: 101.5f (High) fever of 101.5 degrees Fahrenheit.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
I caught covid. I had a headache, that's the way it started. I also had a slight rapid heart beat. I had a slight fever, 100.8. I had back ache near the kidney area. I also had a sore throat only on the left side. I guess I was also a little congested. I was also very lethargic.
mom described rhythmic convuls movements during nap p/last immun; pt recvd ped DT 16MAY94 vax;
BLOOD IN URINE; This spontaneous report received from a patient concerned a 70 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included non smoker, high blood pressure, and high cholesterol, and other pre-existing medical conditions included patient has no known allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1802025, expiry: UNKNOWN) dose was not reported, administered on 08-MAR-2021 to Right Deltoid for prophylactic vaccination at noon.. No concomitant medications were reported. On 08-MAR-2021 16:15, the subject experienced blood in urine. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from blood in urine. This report was non-serious.; Sender's Comments: V0 Medical assessment comment not required as per standard operating procedure as the case assessed as non-serious.
Parents report high fever and rash. Taken to ED, where patient was diagnosed with ear infection. Parents are sure this was a reaction to immunizations.
Postural orthostatic tachycardia syndrome (POTS); Presyncope; Fatigue; Dizziness; Headache; This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a 42-year-old female patient (pt). Information on the patient's concurrent conditions, medical history or concomitant therapy was not reported. On an unspecified date, the pt was vaccinated with quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) injection (lot#, expiration date, dose, route of administration and anatomical location were not reported) as prophylaxis. On an unspecified date in 2013, the pt experienced following vaccination, postural orthostatic tachycardia syndrome (POTS), headache, dizziness, fatigue and presyncope.  The outcome of all the events was not provided. The reporter considered all events to be related to quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL). This is one of multiple cases from the same reporter.; Sender's Comments:  US-009507513-2301USA007523: US-009507513-2301USA007524: US-009507513-2301USA007593: US-009507513-2301USA007602: US-009507513-2301USA007595: US-009507513-2301USA007596: US-009507513-2301USA007597: US-009507513-2301USA007598: US-009507513-2301USA007498: US-009507513-2301USA007600: US-009507513-2301USA007601: US-009507513-2301USA007522: US-009507513-2301USA007521: US-009507513-2301USA007594:
On 1-28-19, patient reported that vaccine given in left arm got hot, red and was itching. Left arm felt weak, area of injection was hard.
No reaction first 2 days - 3rd day muscle soreness 4th day arm itchy, red, swollen - 5th day headache, tight chest no hives. 11 x 17 cm red swollen indurated (L) arm.
Heart palpitations, pvcs, angina, further hypertension, all requiring new medications. Elevated d-dimer.
patient felt arm and chest tightness - made patient wait another 15 minutes and he was feeling better - counseled to report an addition chest tightness and to be particularly vigilant around day 5 - will follow up with patient on day 5
Abnormal bleeding x 30 days, onset two days post vaccine. Severe cramping associated with bleeding, symptoms not experienced in prior 30 years since menstruation began.  Painful ovulation with cysts.
Pt. presented in clinic with c/o chest pain and rapid heart rate. B/P 108/75 P-188 R20 Temp 98.2 c/o shortness of breath. O2 Sat 97-98% room Air. EMS called IV 09 NS Oko. SVT 188-unretrived by vagal maneuversx2 with no conversion converted sinus with bmg IV adenoids. Previous hx 4yrs ago. Transported by EMS to hospital. ER- 12/08/09 CBC/CKMB ED panel roponir, magnesien within normal limits.
Pt received this vaccine in error.  MA did not pay attention and gave this mono valent dose when the patient should have had a bivalent booster dose.
This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm was a little bit sore) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination. No Medical History information was reported.On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Arm was a little bit sore). At the time of the report, PAIN IN EXTREMITY (Arm was a little bit sore) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.No concomitant medications were reported. No treatment medications were reported.This case was linked to MOD-2021-388704, MOD-2021-388705 (Patient Link).
GENITAL HERPES OUTBREAK; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. The patient's concurrent conditions included genital herpes.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 10-MAR-2021 for prophylactic vaccination. The batch no was not known and has been requested. No concomitant medications were reported.  On an unspecified date, the subject experienced genital herpes outbreak. Patient received vaccination on Wednesday evening the 10th. The next day, started having indications of genital herpes outbreak. Patient had this condition for years and know the symptoms. Patient not had an outbreak in over a year. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of genital herpes outbreak was not reported. This report was  non-serious.; Sender's Comments: MAC not required per standard procedure as the case assessed as non-serious.
pt recv vax; episode of screaming for 7 hr & was inconsolable; called HD & MD gave phenergan supp.;
it itches a little; injection site is still swollen; it is a little sore; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (it itches a little), VACCINATION SITE SWELLING (injection site is still swollen) and VACCINATION SITE PAIN (it is a little sore) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for COVID-19 immunisation.     No Medical History information was reported.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (it itches a little), VACCINATION SITE SWELLING (injection site is still swollen) and VACCINATION SITE PAIN (it is a little sore). At the time of the report, VACCINATION SITE PRURITUS (it itches a little), VACCINATION SITE SWELLING (injection site is still swollen) and VACCINATION SITE PAIN (it is a little sore) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided.   No treatment was reported for the events.
Information has been received from a physician concerning a 10-12 year old female with no allergies or reported medical history who was vaccinated with Gardasil via injection.  The physician reported that after the first and second dose of Gardasil the patient had a rash on her face that lasted for about a week.  As of 20-Nov-2007 the patient had recovered and the physician was not sure if they were going to continue with the rest of the series.  Additional information has been requested.
right eye was swollen; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (005570). The reporter is the parent.  A 9 year-old female patient received BNT162b2 (BNT162B2), administration date 15Jan2022 (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: EYE SWELLING (non-serious) with onset 16Jan2022, outcome "unknown", described as "right eye was swollen". The lot number for BNT162b2 was not provided and will be requested during follow up.
Information has been received from a doctor of dental science concerning his 38 year old son-in-law who on 9/27/01 was vaccinated with a dose of MMRII. On approx. 9/27/01, the pt developed either an acute and severe asthma attack or an anaphylactic reaction. The pt gave himself a shot of epinephrine and went to the ER where he was treated and released. Upon internal review, acute and severe asthma attack and anaphylactic reaction were determined to be "Other Important Medical Events". Additional information has been requested.
Initial misuse report received from healthcare professional on 25 October 2013. The cases were received on 21 March 2014. An expired dose of FLUZONE was administered (no other information was provided regarding the patient). No adverse event was reported. List of documents held by sender: none.
Experienced 60mm x 40mm painful erythema to right deltoid area. Denies any fever, nausea, vomiting, or malaise.
Red spots on back and front/I have red round spots on my arm can i be elergic to the vaccine of moderna; Itchy; Feeling shut down; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Red spots on back and front/I have red round spots on my arm can i be elergic to the vaccine of moderna), PRURITUS (Itchy) and DEPRESSED MOOD (Feeling shut down) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 05821A and 023621A) for COVID-19 vaccination.     No Medical History information was reported.   On 05-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Sep-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ERYTHEMA (Red spots on back and front/I have red round spots on my arm can i be elergic to the vaccine of moderna), PRURITUS (Itchy) and DEPRESSED MOOD (Feeling shut down). At the time of the report, ERYTHEMA (Red spots on back and front/I have red round spots on my arm can i be elergic to the vaccine of moderna), PRURITUS (Itchy) and DEPRESSED MOOD (Feeling shut down) outcome was unknown.            No concomitant medication were provided by the reporter  No treatment medication were provided by the reporter  patient reports diarrhea and stomach pain from the first dose which was resolved.   This case was linked to MOD-2021-320714 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 15-Sep-2021: The verbatim added to event erythema.
This spontaneous report was received from a physician assistant via a company representative concerning an unspecified adult male patients greater than 26 years old (specific ages were not provided). Patients' concurrent conditions and medical history were not provided. On an unknown date, the patients who are greater than 26 years of age were vaccinated with GARDASIL 9 (dose, route, frequency, Lot No. and expiration date not provided). There was no concomitant medication described. No adverse symptoms were reported. This is one of two reports from the same reporter. Additional information has been requested.
immediate facial hives. no SOB, no signs of anaphylaxis. gave oral benadryl 25 mg and hives immediately resolved. pt stayed in clinic for 30 min and MD reassessed after that time. pt was doing well so pt cleared to leave.